---
title: "Ajanta Pharma Ltd (AJANTPHARM) — Share Price, Financials & Analysis"
symbol: "AJANTPHARM"
company: "Ajanta Pharma Ltd"
canonical: "https://tapetide.com/stocks/AJANTPHARM"
isin: "INE031B01049"
nse_symbol: "AJANTPHARM"
bse_code: "532331"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 43326.43
generated_at: "2026-09-13T18:34:44.543Z"
---

# Ajanta Pharma Ltd (AJANTPHARM)

Canonical page: https://tapetide.com/stocks/AJANTPHARM

## Company

- **NSE Symbol:** AJANTPHARM
- **BSE Code:** 532331
- **ISIN:** INE031B01049
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2000-05-29
- **CEO:** Mr. Yogesh Mannalal Agrawal M.B.A
- **Employees:** 9628
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** ajantapharma.com

## About

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

## Latest Price

- **Price:** ₹3533.4
- **Change:** +13.4 (+0.38%)
- **Open:** ₹3516
- **Day High:** ₹3560
- **Day Low:** ₹3460
- **Previous Close:** ₹3520
- **Volume:** 45547
- **As Of:** 2026-09-11T10:23:04+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:05.752764Z.

- **Market Cap:** ₹43326.43 Cr
- **Classification:** Midcap
- **P/E (reported):** 38.7
- **P/E (TTM):** 38.9
- **EPS (TTM):** ₹90.84
- **EPS (reported):** ₹67.81
- **Book Value:** ₹362.28
- **Price to Book:** 9.71
- **Dividend Yield:** 0.91%
- **ROE:** 23.33%
- **ROCE:** 29.41%
- **Debt to Equity:** 0.06
- **Revenue (yearly):** ₹5624.9 Cr
- **Net Income:** ₹1056 Cr
- **EBITDA:** ₹1566.9 Cr
- **52-Week High:** ₹3796
- **52-Week Low:** ₹2329.9
- **RSI (14):** 49.08

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Falling
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 83.65 | 9% |
| growth | 59.61 | 9% |
| momentum | 40.26 | 12% |
| ownership | 43.17 | 24% |
| quality | 58.01 | 22% |
| valuation | 60.74 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.2%
- Company has been maintaining a healthy dividend payout of 50.1%

### Weaknesses

- Stock is trading at 9.75 times its book value
- Promoter holding has decreased over last quarter: -2.76%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -54.27% | -32.59% | -5.79% |
| ebitda margin growth | 25.25% | -2.42% | -4.82% | -7.84% |
| net income growth | 25.31% | 14.73% | 24% | 12% |
| revenue growth | 14.42% | 18.6% | 13% | 14% |
| roce | 28.76% | -2.32% | -1.84% | 27.54% |
| roe | 25.32% | -3.91% | 23.5% | 6.87% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1028 | 1105 | 1054 | 1145 | 1187 | 1146 | 1170 | 1303 | 1354 | 1375 | 1422 | 1626 |
| Expenses | 738 | 791 | 776 | 815 | 875 | 825 | 873 | 951 | 1026 | 993 | 1088 | 1202 |
| Operating Profit | 291 | 314 | 278 | 330 | 311 | 321 | 297 | 351 | 328 | 382 | 333 | 424 |
| OPM % | 28 | 28 | 26 | 29 | 26 | 28 | 25 | 27 | 24 | 28 | 23 | 26 |
| Other Income | 21 | 14 | 36 | 26 | 19 | 30 | 18 | 26 | 59 | 25 | 61 | 71 |
| Interest | 2 | 2 | 2 | 1 | 6 | 8 | 6 | 5 | 3 | 5 | 2 | 3 |
| Depreciation | 34 | 34 | 34 | 34 | 34 | 36 | 40 | 41 | 43 | 44 | 45 | 44 |
| Profit before tax | 276 | 291 | 278 | 322 | 290 | 307 | 269 | 331 | 341 | 359 | 347 | 447 |
| Tax % | 29 | 28 | 27 | 24 | 25 | 24 | 16 | 23 | 24 | 24 | 23 | 25 |
| Net Profit | 195 | 210 | 203 | 246 | 216 | 233 | 225 | 255 | 260 | 274 | 267 | 334 |
| EPS in Rs | 15.24 | 16.39 | 15.82 | 19.68 | 17.33 | 18.64 | 18.03 | 20.44 | 20.83 | 21.91 | 21.35 | 26.75 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2126 | 2055 | 2588 | 2890 | 3341 | 3743 | 4209 | 4648 | 5453 | 5776 |
| Expenses | 1467 | 1489 | 1904 | 1889 | 2408 | 2934 | 3037 | 3379 | 3953 | 4309 |
| Operating Profit | 658 | 567 | 683 | 1001 | 933 | 808 | 1172 | 1269 | 1500 | 1467 |
| OPM % | 31 | 28 | 26 | 35 | 28 | 22 | 28 | 27 | 28 | 25 |
| Other Income | 24 | 21 | 88 | 24 | 112 | 74 | 85 | 85 | 67 | 217 |
| Interest | 0 | 1 | 12 | 8 | 10 | 6 | 7 | 21 | 16 | 14 |
| Depreciation | 60 | 72 | 96 | 116 | 125 | 131 | 135 | 144 | 173 | 176 |
| Profit before tax | 623 | 514 | 664 | 900 | 909 | 745 | 1114 | 1189 | 1378 | 1493 |
| Tax % | 25 | 25 | 30 | 27 | 22 | 21 | 27 | 23 | 23 | — |
| Net Profit | 469 | 387 | 468 | 654 | 713 | 588 | 816 | 920 | 1056 | 1135 |
| EPS in Rs | 35.5 | 29.56 | 35.73 | 50.38 | 55.63 | 45.89 | 63.7 | 73.68 | 84.52 | 90.84 |
| Dividend Payout % | 0 | 20 | 24 | 13 | 11 | 15 | 79 | 38 | 33 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 18 | 18 | 18 | 18 | 17 | 17 | 25 | 25 | 25 | 25 |
| Reserves | 1550 | 2024 | 2228 | 2581 | 2978 | 3247 | 3363 | 3542 | 3765 | 4502 |
| Borrowings | 1 | 2 | 36 | 75 | 31 | 25 | 36 | 35 | 47 | 260 |
| Other Liabilities | 254 | 383 | 383 | 619 | 702 | 711 | 1159 | 927 | 1067 | 1250 |
| Total Liabilities | 1823 | 2426 | 2664 | 3293 | 3729 | 4000 | 4582 | 4530 | 4904 | 6037 |
| Fixed Assets | 589 | 1053 | 1178 | 1472 | 1541 | 1512 | 1496 | 1479 | 1762 | 1867 |
| CWIP | 339 | 61 | 262 | 132 | 108 | 153 | 209 | 256 | 176 | 258 |
| Investments | 182 | 190 | 78 | 79 | 176 | 147 | 535 | 349 | 464 | 588 |
| Other Assets | 713 | 1122 | 1147 | 1610 | 1904 | 2188 | 2341 | 2446 | 2502 | 3324 |
| Total Assets | 1823 | 2426 | 2664 | 3293 | 3729 | 4000 | 4582 | 4530 | 4904 | 6037 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 609 | 281 | 375 | 457 | 576 | 562 | 792 | 785 | 1157 | 529 |
| Cash from Investing Activity | -383 | -256 | -223 | -224 | -282 | -74 | -560 | 65 | -377 | -429 |
| Cash from Financing Activity | -202 | 0 | -147 | -129 | -318 | -460 | -108 | -1051 | -733 | -168 |
| Net Cash Flow | 24 | 25 | 4 | 104 | -24 | 28 | 124 | -201 | 47 | -68 |
| Free Cash Flow | 313 | 19 | 32 | 228 | 417 | 431 | 618 | 646 | 840 | 169 |
| CFO/OP | 110 | 64 | 87 | 89 | 81 | 86 | 117 | 94 | 117 | 59 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 59 | 79 | 82 | 109 | 93 | 111 | 103 | 108 | 93 | 124 |
| Inventory Days | 186 | 315 | 415 | 276 | 434 | 347 | 283 | 283 | 308 | 289 |
| Days Payable | 157 | 224 | 214 | 202 | 212 | 143 | 147 | 159 | 155 | 168 |
| Cash Conversion Cycle | 88 | 170 | 282 | 184 | 315 | 315 | 240 | 233 | 246 | 246 |
| Working Capital Days | 65 | 103 | 113 | 108 | 126 | 140 | 83 | 119 | 97 | 111 |
| ROCE % | 46 | 34 | 24 | 27 | 32 | 29 | 23 | 32 | 32 | 35 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 66.21% | 66.21% | 66.21% | 66.27% | 66.26% | 66.26% | 66.26% | 66.26% | 66.25% | 66.25% | 66.25% | 63.48% |
| FIIs | 9.99% | 9.11% | 8.54% | 8.36% | 9.11% | 9.26% | 8.86% | 8.86% | 8.53% | 7.98% | 8.26% | 7.68% |
| DIIs | 14.91% | 16.01% | 17.49% | 17.41% | 17.1% | 17.02% | 17.48% | 17.5% | 17.9% | 18.58% | 18.37% | 21.8% |
| Government | 0% | 0% | 0% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0% |
| Public | 7.21% | 7.07% | 6.91% | 7.08% | 6.71% | 6.67% | 6.63% | 6.59% | 6.53% | 6.44% | 6.35% | 6.27% |
| Others | 1.68% | 1.59% | 0.84% | 0.86% | 0.8% | 0.79% | 0.76% | 0.79% | 0.79% | 0.76% | 0.77% | 0.76% |
| No. of Shareholders | 56277 | 54351 | 55488 | 70316 | 64315 | 66896 | 70827 | 68882 | 67785 | 65409 | 67955 | 65296 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 7 / 7 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 3525.5 | Buy |
| EMA (10) | 3534.39 | Sell |
| SMA (20) | 3573.16 | Sell |
| EMA (20) | 3538.47 | Sell |
| SMA (50) | 3497.19 | Buy |
| EMA (50) | 3468.54 | Buy |
| SMA (100) | 3281.58 | Buy |
| EMA (100) | 3321.02 | Buy |
| SMA (200) | 3039.49 | Buy |
| EMA (200) | 3121.75 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.39 | Neutral |
| MACD (12,26,9) | 5.39 | Sell |
| Stochastic (14,3,3) | 40.55 | Neutral |
| ADX (14) | 17.54 | Neutral |
| Williams %R (14) | -55.02 | Neutral |
| ATR (14) | 98.1 | Neutral |
| ROC (12) | -0.52 | Sell |
| Stoch RSI (14) | 48.76 | Neutral |
| UO (7,14,28) | 55.97 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 10 | 66.67% |
| Hold | 3 | 20% |
| Sell | 2 | 13.33% |

Based on 15 analyst ratings, observed at 2026-09-11T04:35:03.550657+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-31 | [Participation In Investor Conference](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca71983f-a6fd-422f-8cec-88eba2d1a6fc.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e68b250-9707-4653-b325-2705d55c3495.pdf) |
| 2026-08-27 | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CCB51547_60DA_4033_9747_926B443CA2FB_153126.pdf) |
| 2026-08-19 | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99308F72_4198_4BAC_8D40_16B15AE59AA9_174111.pdf) |
| 2026-08-14 | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EC446B24_BE29_4054_A921_651D90A84E33_124958.pdf) |
| 2026-08-05 | [Participation In Investor Conference](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83cfd684-90bd-48a0-b727-57c27def4298.pdf) |
| 2026-07-31 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91015d86-8504-4deb-af09-5d62d4012b9f.pdf) |
| 2026-07-30 | [Board Meeting Outcome for BM Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edf6dc2d-2933-40f8-8145-0f71f6d2b3c9.pdf) |
| 2026-07-30 | [Corporate Action-Board approves Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d51462c1-fe66-468c-9595-0def85b1c29f.pdf) |
| 2026-07-30 | [Record Date Intimation For Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5904943c-7a76-4df3-b3fa-cf481fd3a8c9.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4238fdcf-26e1-4131-8a9a-e4035093f86a.pdf) |
| 2026-05-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0729ee8-243b-4d3c-8b4a-d9c198cc68a0.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb27f929-a2a1-4ecf-a6b8-4c3c9750cf12.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e375f416-b0e8-4573-987d-98acbe50ee81.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f4616fe-ef4e-4b4e-847a-c120c78b6669.pdf) |
| 2025-05-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5e6cc3b-3f5e-4dcf-8ad2-0eed53ec508b.pdf) |
| 2025-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=935d8784-73b0-47a4-acb3-00e8f4ebac68.pdf) |
| 2024-10-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca0017a7-cb7c-4b0e-865e-e09358d8b46d.pdf) |
| 2024-08-02 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abb0b970-f53a-4007-ac6a-cd1d1f4a2a3b.pdf) |
| 2024-05-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a62da3c-8611-46f8-ad58-e259f136d1a5.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Aug 2022 | [Concall - Aug 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/694ff1ee-1c91-42d0-aeb1-56e94bb44931.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-30 | [Results For 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd3e31f5-42d0-4d1a-86c6-8c339a7e2cd0.pdf) |
| 2026-05-05 | [PFA Financial Results For The Quarter And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f8e1f02-e0b0-425b-ae23-a548b46cc134.pdf) |
| 2026-01-30 | [Unaudited Financial Results For Quarter Ended 31St December 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62f9a571-200b-4472-bb3f-3a7a1cd649cc.pdf) |
| 2025-11-03 | [Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3ae3f4a-9a49-4da7-97c8-29fdbdce241d.pdf) |
| 2025-07-28 | [Unaudited (Consolidated & Standalone) Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cf818b5-e94c-4440-983a-30cdf70e514c.pdf) |
| 2025-04-30 | [PFA Audited (Consolidated & Standalone) Financial Results For The Quarter And Year Ended 31St March 2025 Pursuant To Regulation 33 Of SEBI (LODR).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c209dff-01ae-4656-8d9d-b3db7504ee8b.pdf) |
| 2025-01-30 | [Unaudited (Consolidated & Standalone) Financial Results For The Quarter And Nine Months Ended 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c389b762-9030-46e2-9785-2ce8f0dba0dc.pdf) |
| 2024-10-28 | [Unaudited (Consolidated & Standalone) Financial Results For The Quarter And Half Year Ended 30.09.2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf9aa7db-5f4d-4190-af0d-0cf157f0d3aa.pdf) |
| 2024-07-30 | [Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0207d4a4-925e-4275-8915-f1c7e21b471c.pdf) |
| 2024-05-02 | [Results-Financial Results For 03,31,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87b56f4f-8d55-42ce-9845-5f889c3937d8.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83a437d2-aa01-4ebb-96c3-698175be2de9.pdf) |
| 2026-01-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5062da09-f6b0-4e57-8d61-dd6a1fe77061.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e8b4fc-86ad-4566-b08b-d98d4f7cb04e.pdf) |
| 2025-04-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46786a7-3457-4077-8803-ef79b49e5f0b.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a82ac20-ddeb-41ba-93d8-0f472fde7285.pdf) |
| 2024-07-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ea3a5fe-d177-4412-902d-a197f348d783.pdf) |
| 2024-05-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81a65223-88bd-453b-9cc4-a08efdc1de73.pdf) |
| 2024-01-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43de6454-fe17-4ba7-a7bc-63b1e4b77b5e.pdf) |
| 2023-10-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2cd9541-eea3-4bc9-a9c9-546d4e768153.pdf) |
| 2023-07-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d59261e-c947-4030-bc26-a7398484aeab.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Analyst/institutional meeting on 10-Mar-2026 at Investec India Promoter & Founder Conference, Trident BKC. | [Participation In Investor Conference 9 Mar - Analyst/institutional meeting on 10-Mar-2026 at Investec India Promoter & Founder Conference, Trident BKC.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70caf9c8-cbd3-4f6c-83b0-afa4dece725c.pdf) |
| 8 May - Pls find enclosed Written Transcript of Earnings Call held on 5th May 2026. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 8 May - Pls find enclosed Written Transcript of Earnings Call held on 5th May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c0729ee8-243b-4d3c-8b4a-d9c198cc68a0.pdf) |
| 6 May - Newspaper Publication of Financial Results for the quarter and year ended 31st March 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 May - Newspaper Publication of Financial Results for the quarter and year ended 31st March 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3e5de612-3b10-4e89-9f97-b2a18fe6f781.pdf) |
| 6 Apr - Regulation 74(5) certificate received for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Regulation 74(5) certificate received for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/35ee2a76-e223-4618-bf28-c986cae87e93.pdf) |
| 5 May - Board approved reappointment of internal, cost and tax auditors for FY2026-27. | [Disclosure As Per Regulation 30 Of SEBI (LODR) 5 May - Board approved reappointment of internal, cost and tax auditors for FY2026-27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c99710de-4216-4fb6-b988-1bc539309e21.pdf) |
| 5 May - Audio recording of 5 May 2026 earnings call uploaded; transcript to follow. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 5 May - Audio recording of 5 May 2026 earnings call uploaded; transcript to follow.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fcb6224e-a727-4161-b746-8271a1f6ba22.pdf) |
| 5 May - Ajanta Pharma granted 145,000 ESOPs and cancelled 850 options on 5 May 2026. | [Intimation Of Grant And Cancellation Of Options 5 May - Ajanta Pharma granted 145,000 ESOPs and cancelled 850 options on 5 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d48386ea-3762-43f8-a1b3-9f490c950a9c.pdf) |
| 4h - Ajanta Pharma reported FY26 revenue of ₹5,453 crore, PAT ₹1,056 crore; tax search impact remains unascertainable. | [PFA Financial Results For The Quarter And Year Ended 31.03.2026 4h - Ajanta Pharma reported FY26 revenue of ₹5,453 crore, PAT ₹1,056 crore; tax search impact remains unascertainable.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0f8e1f02-e0b0-425b-ae23-a548b46cc134.pdf) |
| 2d - Ajanta Pharma reported FY26 results; revenue rose 17%, PAT 15%, and noted an income tax search notice. | [Board Meeting Outcome for Outcome Of Board Meeting 2d - Ajanta Pharma reported FY26 results; revenue rose 17%, PAT 15%, and noted an income tax search notice.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1bdab2cb-27eb-4f10-9b9c-e8ad6760a42b.pdf) |
| 26 Mar - Trading window closed from 1 April 2026 until 48 hours after results for quarter/year ended 31 March 2026. | [Closure of Trading Window 26 Mar - Trading window closed from 1 April 2026 until 48 hours after results for quarter/year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d7cad5a-19f5-4ad1-ba26-eb2863f4af82.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9aa8b4aa-2d68-4133-aca5-456656e479a3.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d052b71a-1a88-4eb9-9613-be4da52ec369.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34cfa17e-5471-4104-8264-eddcbd1dfd1e.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b20f31a7-e77a-42e1-9eeb-ccdb0a7b3320.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532331/73503532331.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:34:44.543Z.